Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07288554) titled 'A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Bambusa Therapeutics
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
Drug: BBT002
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: September 5, 2025
Target Sample Size: 68
Countries of Recruitment:
China
To ...